IT7851499A0 - Procedimento per la produzione di derivati della xantina e prodotto relativo - Google Patents

Procedimento per la produzione di derivati della xantina e prodotto relativo

Info

Publication number
IT7851499A0
IT7851499A0 IT7851499A IT5149978A IT7851499A0 IT 7851499 A0 IT7851499 A0 IT 7851499A0 IT 7851499 A IT7851499 A IT 7851499A IT 5149978 A IT5149978 A IT 5149978A IT 7851499 A0 IT7851499 A0 IT 7851499A0
Authority
IT
Italy
Prior art keywords
procedure
production
related product
xanthine derivatives
xanthine
Prior art date
Application number
IT7851499A
Other languages
English (en)
Other versions
IT1109208B (it
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of IT7851499A0 publication Critical patent/IT7851499A0/it
Application granted granted Critical
Publication of IT1109208B publication Critical patent/IT1109208B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT51499/78A 1977-10-14 1978-10-13 Procedimento per la produzione di derivati della xantina e prodotto relativo IT1109208B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (2)

Publication Number Publication Date
IT7851499A0 true IT7851499A0 (it) 1978-10-13
IT1109208B IT1109208B (it) 1985-12-16

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51499/78A IT1109208B (it) 1977-10-14 1978-10-13 Procedimento per la produzione di derivati della xantina e prodotto relativo

Country Status (21)

Country Link
US (1) US4233303A (it)
EP (1) EP0001735B1 (it)
JP (1) JPS5479296A (it)
AT (1) AT363491B (it)
AU (1) AU521585B2 (it)
CA (1) CA1109470A (it)
CS (1) CS208756B2 (it)
DD (1) DD139855A5 (it)
DE (1) DE2862017D1 (it)
DK (1) DK148260C (it)
FI (1) FI66383C (it)
HK (1) HK6385A (it)
HU (1) HU180219B (it)
IE (1) IE47884B1 (it)
IT (1) IT1109208B (it)
NO (1) NO147562C (it)
NZ (1) NZ188566A (it)
SE (1) SE416810C (it)
SG (1) SG85584G (it)
SU (1) SU755199A3 (it)
ZA (1) ZA785335B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
RU2367442C2 (ru) 2003-04-25 2009-09-20 Новокардия, Инк. Способ нормализации мочеиспускания при нарушении функции почек
JP2007532671A (ja) * 2004-04-16 2007-11-15 ノヴァカーディア，インク． アデノシンａ１受容体アンタゴニストおよびアルドステロン阻害剤を含む併用療法
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
CS208756B2 (en) 1981-09-15
DK453778A (da) 1979-04-15
SE416810B (sv) 1981-02-09
FI783126A (fi) 1979-04-15
AU4036578A (en) 1980-04-17
EP0001735B1 (en) 1982-09-01
JPS5479296A (en) 1979-06-25
SE416810C (sv) 1982-05-11
NO147562C (no) 1983-05-18
DK148260B (da) 1985-05-20
ATA714478A (de) 1980-09-15
SE7711581L (sv) 1979-04-14
NZ188566A (en) 1984-07-06
IE47884B1 (en) 1984-07-11
AU521585B2 (en) 1982-04-22
HK6385A (en) 1985-02-01
FI66383B (fi) 1984-06-29
CA1109470A (en) 1981-09-22
NO147562B (no) 1983-01-24
DD139855A5 (de) 1980-01-23
ZA785335B (en) 1979-09-26
IT1109208B (it) 1985-12-16
FI66383C (fi) 1984-10-10
IE782041L (en) 1979-04-14
DK148260C (da) 1986-02-10
SU755199A3 (en) 1980-08-07
HU180219B (en) 1983-02-28
NO783471L (no) 1979-04-18
EP0001735A1 (en) 1979-05-02
DE2862017D1 (en) 1982-10-28
SG85584G (en) 1985-06-07
AT363491B (de) 1981-08-10
US4233303A (en) 1980-11-11

Similar Documents

Publication Publication Date Title
IT7851499A0 (it) Procedimento per la produzione di derivati della xantina e prodotto relativo
IT1088554B (it) Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
IT1093078B (it) Apparecchio e procedimento per la produzione di derivati cellulosici
IT1105176B (it) Derivati della morfina e relativo procedimento di produzione
IT1103464B (it) Procedimento per la produzione di derivati benzimidazolici
IT1106111B (it) Alfa-alogenometil derivati delle ammine e relativo procedimento di produzione
IT7850401A0 (it) Procedimento per la produzione di derivati di 1/2/4-triazin-5-one
IT7847887A0 (it) Procedimento per la produzione di derivati di benzencarbossammide e benzensolfonammide e prodotto ottenuto
IT1143583B (it) Derivati della idantoina e relativo procedimento di produzione
IT1105172B (it) Derivati della morfina e relativo procedimento di produzione
IT1143671B (it) Procedimento per la fabbricazione di triptofano e di suoi derivati
IT1106121B (it) Derivati 25-alchilcolesterolici e relativo procedimento di produzione
IT1107787B (it) Procedimento per la produzione di derivati di alcaloidi pentaciclici prodotto ottenuto e relativo procedimento di impiego nella sintesi di composti della eburnamenina
IT7825800A0 (it) Procedimento per la fabbricazione di p-idrossifenilglicina e suoi derivati
IT7848192A0 (it) Procedimento per la produzione di derivati di 9-2-idrossietossimetilguanina e prodotto ottenuto
IT1156718B (it) Procedimento per la produzione di 1-n-(omega-ammino-alfa-idrossialcanoil)kanamicine e prodotto relativo
IT7852072A0 (it) Procedimenti per la produzione di derivati della fenossialcanolamina
IT7850463A0 (it) Derivati alfa-alogenometilici di amminoacidi e relativo procedimentodi produzione
IT7850147A0 (it) Derivati di 4-omoisotwistano e relativo procedimento di produzione
IT1110876B (it) Procedimento per la preparazione di 1-idrossiaporfin derivati e prodotto ottenuto
IT1164693B (it) Derivati della idantoina e relativo procedimento di produzione
IT7849485A0 (it) Composizione farmaceutica comprendente prostaciclina o suoi derivati e relativo procedimento di produzione
IT1061216B (it) Procedimento per la produzione di xantinilalchilnortropin derivati quaternari e prodotto ottenuto
IT7847551A0 (it) Derivati acilammino-crotonici e relativo procedimento di produzione
IT8050426A0 (it) Derivati nitrotiazolinici e relativo procedimento di produzione